{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:15:41Z","timestamp":1781842541870,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00296-019-04311-x","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T16:08:53Z","timestamp":1556208533000},"page":"1045-1051","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1300-3131","authenticated-orcid":false,"given":"Emre","family":"Bilgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0911-9078","authenticated-orcid":false,"given":"\u00d6mer","family":"Dizdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6924-9467","authenticated-orcid":false,"given":"Deniz Can","family":"G\u00fcven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5885-4023","authenticated-orcid":false,"given":"Serdar","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5483-8584","authenticated-orcid":false,"given":"\u00d6zge","family":"Aybi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-5683","authenticated-orcid":false,"given":"B\u00fc\u015fra","family":"F\u0131rlatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0730-8959","authenticated-orcid":false,"given":"R\u0131za Can","family":"Karda\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3537-3793","authenticated-orcid":false,"given":"Tolga","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2594-6794","authenticated-orcid":false,"given":"Mutlu Kadir","family":"Hayran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7129-2109","authenticated-orcid":false,"given":"Umut","family":"Kalyoncu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-7868","authenticated-orcid":false,"given":"Seza","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"issue":"5","key":"4311_CR1","first-page":"91","volume":"48","author":"H Heller","year":"1955","unstructured":"Heller H, Kariv J, Sherf L, Sohar E (1955) Familial Mediterranean fever. Harefuah 48(5):91\u201394","journal-title":"Harefuah"},{"issue":"6 Suppl 102","key":"4311_CR2","first-page":"97","volume":"34","author":"O Soylemezoglu","year":"2016","unstructured":"Soylemezoglu O, Kandur Y, Gonen S, Duzova A, Ozcakar ZB, Fidan K, Yalcinkaya F (2016) Familial Mediterranean fever gene mutation frequencies in a sample Turkish population. Clin Exp Rheumatol 34(6 Suppl 102):97\u2013100","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"4311_CR3","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s10067-017-3715-5","volume":"36","author":"M Alghamdi","year":"2017","unstructured":"Alghamdi M (2017) Familial Mediterranean fever, review of the literature. Clin Rheumatol 36(8):1707\u20131713. \n                    https:\/\/doi.org\/10.1007\/s10067-017-3715-5","journal-title":"Clin Rheumatol"},{"issue":"5","key":"4311_CR4","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1182\/blood-2008-01-134932","volume":"112","author":"JJ Chae","year":"2008","unstructured":"Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, Masters SL, Gumucio DL, Shoham NG, Kastner DL (2008) The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 112(5):1794\u20131803. \n                    https:\/\/doi.org\/10.1182\/blood-2008-01-134932","journal-title":"Blood"},{"issue":"4","key":"4311_CR5","first-page":"299","volume":"130","author":"W Doerr","year":"1985","unstructured":"Doerr W (1985) Cohnheim's inflammation doctrine and the current debate. Zentralblatt fur allgemeine Pathologie u pathologische Anatomie 130(4):299\u2013306","journal-title":"Zentralblatt fur allgemeine Pathologie u pathologische Anatomie"},{"issue":"45","key":"4311_CR6","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.3748\/wjg.v19.i45.8181","volume":"19","author":"S Nakamura","year":"2013","unstructured":"Nakamura S, Matsumoto T (2013) Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management. World J Gastroenterol 19(45):8181\u20138187. \n                    https:\/\/doi.org\/10.3748\/wjg.v19.i45.8181","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4311_CR7","first-page":"316","volume":"28","author":"T Koizumi","year":"1970","unstructured":"Koizumi T, Kamata T, Nakamura M, Sugawa Y, Mitsuya N (1970) Case of primary cancer of the liver developing in the course of chronic hepatitis. Nihon rinsho Jpn J Clin Med 28(2):316\u2013319","journal-title":"Nihon rinsho Jpn J Clin Med"},{"issue":"1","key":"4311_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF03001379","volume":"15","author":"TM Johnson","year":"1948","unstructured":"Johnson TM, Orr TG (1948) Carcinoma of the colon secondary to chronic ulcerative colitis. Am J Dig Dis 15(1):21\u201323","journal-title":"Am J Dig Dis"},{"issue":"9","key":"4311_CR9","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1172\/JCI80007","volume":"125","author":"S Shalapour","year":"2015","unstructured":"Shalapour S, Karin M (2015) Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Investig 125(9):3347\u20133355. \n                    https:\/\/doi.org\/10.1172\/jci80007","journal-title":"J Clin Investig"},{"issue":"19","key":"4311_CR10","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1158\/0008-5472.CAN-17-1340","volume":"77","author":"KD Moynihan","year":"2017","unstructured":"Moynihan KD, Irvine DJ (2017) Roles for innate immunity in combination immunotherapies. Cancer Res 77(19):5215\u20135221. \n                    https:\/\/doi.org\/10.1158\/0008-5472.Can-17-1340","journal-title":"Cancer Res"},{"key":"4311_CR11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3389\/fimmu.2017.01132","volume":"8","author":"M Kantono","year":"2017","unstructured":"Kantono M, Guo B (2017) Inflammasomes and cancer: the dynamic role of the inflammasome in tumor development. Front Immunol 8:1132. \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.01132","journal-title":"Front Immunol"},{"key":"4311_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fimmu.2017.00253","volume":"8","author":"S Ozen","year":"2017","unstructured":"Ozen S, Batu ED, Demir S (2017) Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management. Front Immunol 8:253. \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.00253","journal-title":"Front Immunol"},{"issue":"3","key":"4311_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jaad.2017.09.035","volume":"78","author":"SJ Na","year":"2018","unstructured":"Na SJ, Kang MJ, Yu DS, Han KD, Lee JH, Park YG, Lee YB (2018) Cancer risk in patients with Behcet disease: a nationwide population-based dynamic cohort study from Korea. J Am Acad Dermatol 78(3):464\u2013470.e462. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2017.09.035","journal-title":"J Am Acad Dermatol"},{"issue":"18","key":"4311_CR14","doi-asserted-by":"publisher","first-page":"e3540","DOI":"10.1097\/MD.0000000000003540","volume":"95","author":"KH Yu","year":"2016","unstructured":"Yu KH, Kuo CF, Huang LH, Huang WK, See LC (2016) Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: a nationwide population-based dynamic cohort study in Taiwan. Medicine (Baltimore) 95(18):e3540. \n                    https:\/\/doi.org\/10.1097\/md.0000000000003540","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"4311_CR15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3899\/jrheum.140770","volume":"42","author":"LH Wang","year":"2015","unstructured":"Wang LH, Wang WM, Hsu SM, Lin SH, Shieh CC (2015) Risk of overall and site-specific cancers in Behcet disease: a nationwide population-based study in Taiwan. J Rheumatol 42(5):879\u2013884. \n                    https:\/\/doi.org\/10.3899\/jrheum.140770","journal-title":"J Rheumatol"},{"issue":"1","key":"4311_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/art.40344","volume":"70","author":"R Brenner","year":"2018","unstructured":"Brenner R, Ben-Zvi I, Shinar Y, Liphshitz I, Silverman B, Peled N, Levy C, Ben-Chetrit E, Livneh A, Kivity S (2018) Familial Mediterranean fever and incidence of cancer: an analysis of 8,534 Israeli patients with 258,803 person-years. Arthritis Rheumatol 70(1):127\u2013133. \n                    https:\/\/doi.org\/10.1002\/art.40344","journal-title":"Arthritis Rheumatol"},{"key":"4311_CR17","unstructured":"Turkish National Cancer Registry (TNCR) (2014). https:\/\/hsgm.saglik.gov.tr\/tr\/kanser-istatistikleri\/yillar\/495-2014-y\u0131l\u0131-t\u00fcrkiye-kanser-istatistikleri.html. Accessed 1 July 2018"},{"key":"4311_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/nyas.12416","volume":"1311","author":"NA Berger","year":"2014","unstructured":"Berger NA (2014) Obesity and cancer pathogenesis. Ann N Y Acad Sci 1311:57\u201376. \n                    https:\/\/doi.org\/10.1111\/nyas.12416","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"4311_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrrheum.2010.181","volume":"7","author":"I Ben-Zvi","year":"2011","unstructured":"Ben-Zvi I, Livneh A (2011) Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 7(2):105\u2013112. \n                    https:\/\/doi.org\/10.1038\/nrrheum.2010.181","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4311_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","volume":"10","author":"P Brito-Zeron","year":"2017","unstructured":"Brito-Zeron P, Kostov B, Fraile G, Caravia-Duran D, Maure B, Rascon FJ, Zamora M, Casanovas A, Lopez-Dupla M, Ripoll M, Pinilla B, Fonseca E, Akasbi M, de la Red G, Duarte-Millan MA, Fanlo P, Guisado-Vasco P, Perez-Alvarez R, Chamorro AJ, Morcillo C, Jimenez-Heredia I, Sanchez-Berna I, Lopez-Guillermo A, Ramos-Casals M (2017) Characterization and risk estimate of cancer in patients with primary Sjogren syndrome. J Hematol Oncol 10(1):90. \n                    https:\/\/doi.org\/10.1186\/s13045-017-0464-5","journal-title":"J Hematol Oncol"},{"key":"4311_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","volume":"42","author":"S Bernatsky","year":"2013","unstructured":"Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin JF, Petri M, Zoma A, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler E, Yelin E, Bae SC, Wallace DJ, Edworthy S, Jacobsen S, Gordon C, Dooley MA, Peschken CA, Hanly JG, Alarcon GS, Nived O, Ruiz-Irastorza G, Isenberg D, Rahman A, Witte T, Aranow C, Kamen DL, Steinsson K, Askanase A, Barr S, Criswell LA, Sturfelt G, Patel NM, Senecal JL, Zummer M, Pope JE, Ensworth S, El-Gabalawy H, McCarthy T, Dreyer L, Sibley J, St Pierre Y, Clarke AE (2013) Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun 42:130\u2013135. \n                    https:\/\/doi.org\/10.1016\/j.jaut.2012.12.009","journal-title":"J Autoimmun"},{"issue":"12","key":"4311_CR22","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/ard.47.12.988","volume":"47","author":"AJ Silman","year":"1988","unstructured":"Silman AJ, Petrie J, Hazleman B, Evans SJ (1988) Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. Ann Rheum Dis 47(12):988\u2013992","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4311_CR23","doi-asserted-by":"publisher","first-page":"e87064","DOI":"10.1371\/journal.pone.0087064","volume":"9","author":"K Larocque","year":"2014","unstructured":"Larocque K, Ovadje P, Djurdjevic S, Mehdi M, Green J, Pandey S (2014) Novel analogue of colchicine induces selective pro-death autophagy and necrosis in human cancer cells. PLoS One 9(1):e87064. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0087064","journal-title":"PLoS One"},{"issue":"10","key":"4311_CR24","first-page":"4025","volume":"30","author":"NM Yunos","year":"2010","unstructured":"Yunos NM, Beale P, Yu JQ, Strain D, Huq F (2010) Studies on combinations of platinum with paclitaxel and colchicine in ovarian cancer cell lines. Anticancer Res 30(10):4025\u20134037","journal-title":"Anticancer Res"},{"issue":"8","key":"4311_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.lfs.2013.07.002","volume":"93","author":"ZY Lin","year":"2013","unstructured":"Lin ZY, Wu CC, Chuang YH, Chuang WL (2013) Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma. Life Sci 93(8):323\u2013328. \n                    https:\/\/doi.org\/10.1016\/j.lfs.2013.07.002","journal-title":"Life Sci"},{"issue":"15","key":"4311_CR26","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1021\/jm500561a","volume":"57","author":"G Regina La","year":"2014","unstructured":"La Regina G, Bai R, Coluccia A, Famiglini V, Pelliccia S, Passacantilli S, Mazzoccoli C, Ruggieri V, Sisinni L, Bolognesi A, Rensen WM, Miele A, Nalli M, Alfonsi R, Di Marcotullio L, Gulino A, Brancale A, Novellino E, Dondio G, Vultaggio S, Varasi M, Mercurio C, Hamel E, Lavia P, Silvestri R (2014) New pyrrole derivatives with potent tubulin polymerization inhibiting activity as anticancer agents including hedgehog-dependent cancer. J Med Chem 57(15):6531\u20136552. \n                    https:\/\/doi.org\/10.1021\/jm500561a","journal-title":"J Med Chem"},{"issue":"2","key":"4311_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.kjms.2015.12.006","volume":"32","author":"ZY Lin","year":"2016","unstructured":"Lin ZY, Kuo CH, Wu DC, Chuang WL (2016) Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines. Kaohsiung J Med Sci 32(2):68\u201373. \n                    https:\/\/doi.org\/10.1016\/j.kjms.2015.12.006","journal-title":"Kaohsiung J Med Sci"},{"issue":"50","key":"4311_CR28","doi-asserted-by":"publisher","first-page":"e1570","DOI":"10.1097\/MD.0000000000001570","volume":"94","author":"MC Kuo","year":"2015","unstructured":"Kuo MC, Chang SJ, Hsieh MC (2015) Colchicine significantly reduces incident cancer in gout male patients: a 12-year cohort study. Medicine (Baltimore) 94(50):e1570. \n                    https:\/\/doi.org\/10.1097\/md.0000000000001570","journal-title":"Medicine (Baltimore)"},{"issue":"10105","key":"4311_CR29","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ (2017) Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet (London, England) 390(10105):1833\u20131842. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(17)32247-x","journal-title":"Lancet (London, England)"},{"issue":"10","key":"4311_CR30","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.autrev.2017.07.022","volume":"16","author":"E Giat","year":"2017","unstructured":"Giat E, Ehrenfeld M, Shoenfeld Y (2017) Cancer and autoimmune diseases. Autoimmun Rev 16(10):1049\u20131057. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2017.07.022","journal-title":"Autoimmun Rev"},{"issue":"5","key":"4311_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.7326\/M17-2812","volume":"169","author":"Raaschou P, Soderling J, Turesson C, Askling J, Group AS","year":"2018","unstructured":"Raaschou P, Soderling J, Turesson C, Askling J, Group AS (2018) Tumor necrosis factor inhibitors and cancer recurrence in Swedish patients with rheumatoid arthritis: a nationwide population-based cohort study. Ann Intern Med 169(5):291\u2013299. \n                    https:\/\/doi.org\/10.7326\/M17-2812","journal-title":"Ann Intern Med"},{"issue":"3","key":"4311_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10238-005-0071-6","volume":"5","author":"JC Hilst van der","year":"2005","unstructured":"van der Hilst JC, Simon A, Drenth JP (2005) Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 5(3):87\u201398. \n                    https:\/\/doi.org\/10.1007\/s10238-005-0071-6","journal-title":"Clin Exp Med"},{"issue":"2","key":"4311_CR33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/annonc\/mdt544","volume":"25","author":"K Hemminki","year":"2014","unstructured":"Hemminki K, Li X, Forsti A, Sundquist J, Sundquist K (2014) Cancer risk in amyloidosis patients in Sweden with novel findings on non-Hodgkin lymphoma and skin cancer. Ann Oncol 25(2):511\u2013518. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdt544","journal-title":"Ann Oncol"},{"issue":"13","key":"4311_CR34","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1084\/jem.20160817","volume":"213","author":"JJ Barrott","year":"2016","unstructured":"Barrott JJ, Kafchinski LA, Jin H, Potter JW, Kannan SD, Kennedy R, Mosbruger T, Wang WL, Tsai JW, Araujo DM, Liu T, Capecchi MR, Lazar AJ, Jones KB (2016) Modeling synovial sarcoma metastasis in the mouse: PI3\u2019-lipid signaling and inflammation. J Exp Med 213(13):2989\u20133005. \n                    https:\/\/doi.org\/10.1084\/jem.20160817","journal-title":"J Exp Med"},{"key":"4311_CR35","doi-asserted-by":"publisher","DOI":"10.15586\/codon.wt.2016.ch12","volume-title":"Wilms tumor","author":"P Maturu","year":"2016","unstructured":"Maturu P (2016) The inflammatory microenvironment in wilms tumors. In: van den Heuvel-Eibrink MM (ed) Wilms tumor. Codon Publications, Brisban. \n                    https:\/\/doi.org\/10.15586\/codon.wt.2016.ch12\n                    \n                  \n                           (Copyright: The Author)"},{"key":"4311_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-0348-0837-8_4","volume":"816","author":"JL Sowers","year":"2014","unstructured":"Sowers JL, Johnson KM, Conrad C, Patterson JT, Sowers LC (2014) The role of inflammation in brain cancer. Adv Exp Med Biol 816:75\u2013105. \n                    https:\/\/doi.org\/10.1007\/978-3-0348-0837-8_4","journal-title":"Adv Exp Med Biol"},{"key":"4311_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcancer.2013.11.005","volume":"24","author":"C Thieblemont","year":"2014","unstructured":"Thieblemont C, Bertoni F, Copie-Bergman C, Ferreri AJ, Ponzoni M (2014) Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type. Semin Cancer Biol 24:33\u201342. \n                    https:\/\/doi.org\/10.1016\/j.semcancer.2013.11.005","journal-title":"Semin Cancer Biol"},{"issue":"5963","key":"4311_CR38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.1184004","volume":"327","author":"JP Ting","year":"2010","unstructured":"Ting JP, Duncan JA, Lei Y (2010) How the noninflammasome NLRs function in the innate immune system. Science 327(5963):286\u2013290. \n                    https:\/\/doi.org\/10.1126\/science.1184004","journal-title":"Science"},{"issue":"5","key":"4311_CR39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00281-014-0434-8","volume":"36","author":"JR Lukens","year":"2014","unstructured":"Lukens JR, Kanneganti TD (2014) Beyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory disease. Semin Immunopathol 36(5):595\u2013609. \n                    https:\/\/doi.org\/10.1007\/s00281-014-0434-8","journal-title":"Semin Immunopathol"},{"issue":"3","key":"4311_CR40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.immuni.2012.01.018","volume":"36","author":"O Gross","year":"2012","unstructured":"Gross O, Yazdi AS, Thomas CJ, Masin M, Heinz LX, Guarda G, Quadroni M, Drexler SK, Tschopp J (2012) Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 36(3):388\u2013400. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2012.01.018","journal-title":"Immunity"},{"issue":"6","key":"4311_CR41","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1053\/j.gastro.2016.08.055","volume":"151","author":"DS Shouval","year":"2016","unstructured":"Shouval DS, Biswas A, Kang YH, Griffith AE, Konnikova L, Mascanfroni ID, Redhu NS, Frei SM, Field M, Doty AL, Goldsmith JD, Bhan AK, Loizides A, Weiss B, Yerushalmi B, Yanagi T, Lui X, Quintana FJ, Muise AM, Klein C, Horwitz BH, Glover SC, Bousvaros A, Snapper SB (2016) Interleukin 1beta mediates intestinal inflammation in mice and patients with interleukin 10 receptor deficiency. Gastroenterology 151(6):1100\u20131104. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2016.08.055","journal-title":"Gastroenterology"},{"issue":"8","key":"4311_CR42","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.4049\/jimmunol.1002046","volume":"185","author":"MH Zaki","year":"2010","unstructured":"Zaki MH, Vogel P, Body-Malapel M, Lamkanfi M, Kanneganti TD (2010) IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J \u0130mmunol (Baltimore, Md: 1950) 185(8):4912\u20134920. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1002046","journal-title":"J \u0130mmunol (Baltimore, Md: 1950)"},{"issue":"45","key":"4311_CR43","doi-asserted-by":"publisher","first-page":"18384","DOI":"10.1073\/pnas.1209171109","volume":"109","author":"SK Drexler","year":"2012","unstructured":"Drexler SK, Bonsignore L, Masin M, Tardivel A, Jackstadt R, Hermeking H, Schneider P, Gross O, Tschopp J, Yazdi AS (2012) Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc Natl Acad Sci USA 109(45):18384\u201318389. \n                    https:\/\/doi.org\/10.1073\/pnas.1209171109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"4311_CR44","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1074\/jbc.M109.064907","volume":"285","author":"M Okamoto","year":"2010","unstructured":"Okamoto M, Liu W, Luo Y, Tanaka A, Cai X, Norris DA, Dinarello CA, Fujita M (2010) Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem 285(9):6477\u20136488. \n                    https:\/\/doi.org\/10.1074\/jbc.M109.064907","journal-title":"J Biol Chem"},{"key":"4311_CR45","doi-asserted-by":"publisher","first-page":"36107","DOI":"10.1038\/srep36107","volume":"6","author":"B Guo","year":"2016","unstructured":"Guo B, Fu S, Zhang J, Liu B, Li Z (2016) Targeting inflammasome\/IL-1 pathways for cancer immunotherapy. Sci Rep 6:36107. \n                    https:\/\/doi.org\/10.1038\/srep36107","journal-title":"Sci Rep"},{"issue":"6","key":"4311_CR46","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1084\/jem.20161707","volume":"214","author":"D Daley","year":"2017","unstructured":"Daley D, Mani VR, Mohan N, Akkad N, Pandian G, Savadkar S, Lee KB, Torres-Hernandez A, Aykut B, Diskin B, Wang W, Farooq MS, Mahmud AI, Werba G, Morales EJ, Lall S, Wadowski BJ, Rubin AG, Berman ME, Narayanan R, Hundeyin M, Miller G (2017) NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med 214(6):1711\u20131724. \n                    https:\/\/doi.org\/10.1084\/jem.20161707","journal-title":"J Exp Med"},{"issue":"1","key":"4311_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/labinvest.2013.126","volume":"94","author":"Q Wei","year":"2014","unstructured":"Wei Q, Mu K, Li T, Zhang Y, Yang Z, Jia X, Zhao W, Huai W, Guo P, Han L (2014) Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab \u0130nvestig J Tech Methods Pathol 94(1):52\u201362. \n                    https:\/\/doi.org\/10.1038\/labinvest.2013.126","journal-title":"Lab \u0130nvestig J Tech Methods Pathol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04311-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04311-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04311-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T23:14:02Z","timestamp":1587683642000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04311-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4311"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04311-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"27 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors have any potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}